Aurdan Capital Management, LLC has filed a Form 13F-HR disclosing its equity holdings as of the close of business on September 30, 2026. The filing, submitted on November 11, 2026, lists a total of 108 securities held by the firm.
The portfolio is diversified across a wide range of sectors, with notable positions in large-cap technology and healthcare companies. Apple Inc. is the largest individual holding, with 2,219,640 shares. Other significant equity positions include Abbott Laboratories (1,876,664 shares), Eli Lilly & Co. (588,954 shares), and Johnson & Johnson (4,745,994 shares). The firm also holds substantial stakes in exchange-traded funds, including Vanguard Specialized Funds Div App ETF (52,262,115 shares) and Vanguard Index Funds Extended Market ETF (10,584,655 shares).
The filing details the specific number of shares held for each security, with the smallest individual position being Norfolk Southern Corporation (690 shares) and the largest ETF holding being the Vanguard Specialized Funds Div App ETF (52,262,115 shares). The report includes a list of 108 distinct equity and ETF positions managed by the firm.
